Lipitor v. Pravachol Studies Raise Questions On Utility Of OTC-Dose Statins
This article was originally published in The Tan Sheet
Executive Summary
Two recently published clinical trials involving statins that report a clear and substantial benefit from intensive LDL-cholesterol lowering versus moderate reduction may dampen prospects for switching the drugs OTC in the U.S